Development and Multicenter Case-Control Validation of Urinary Comprehensive Genomic Profiling for Urothelial Carcinoma Diagnosis, Surveillance, and Risk-Prediction.

Clin Cancer Res · 2023 · PMC10502470 · PMID 37439796

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not achieve significanceno p-value reported

When clinical-risk factors of age, smoking history, gender, grade, and stage were assessed in a univariable model, they did not achieve significance in prediction of future recurrence, suggesting that UroAmp MRD recurrence prediction has significant potential to enable the delivery of personalized and risk-stratified care.

also in 1,397 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.